|
2005 Announcements 15 Dec 2005
Letter to Shareholders re Share Placement
2 Dec 2005
Short Form Prospectus
2 Dec 2005
Appendix 3B
2 Dec 2005
Capital Raising Presentation November 2005
2 Dec 2005
Neuren raises $6.4 million in share placement
24 Nov 2005
Neuren Agreement with Jackson Foundation for Phase 3
9 Nov 2005
Neuren Senior Scientist inducted to US Institute of Medicine
31 Oct 2005
Appendix 4C - quarterly cash flows
14 Oct 2005
Shareholder Update - Oct 2005
4 Oct 2005
Neuren Wins NZ Biotechnology Co of the Year Award
3 Oct 2005
Response to ASX Share Price Query
6 Sep 2005
Parkinsons & Hypertension patents issued
31 Aug 2005
Appendix 4D
31 Aug 2005
Interim Report 2005
30 Aug 2005
Neuren initiates Phase 2 trial
24 Aug 2005
US Army Presents Neuren Research Results
8 Aug 2005
Appendix 3B
29 Jul 2005
Appendix 4C - quarterly cash flows
11 Jul 2005
Walter Reed NNZ-2566 Contract Expanded
6 Jun 2005
FDA advances Neuren to Phase 3
30 May 2005
Results of Annual General Meeting
30 May 2005
CEO Presentation to AGM
20 May 2005
Appendix 3B
29 Apr 2005
Appendix 4C - quarterly cash flows
22 Apr 2005
Notice of AGM
31 Mar 2005
Annual Report 2004
17 Mar 2005
Neuren CEO Update March 2005
15 Mar 2005
Walter Reed Collaboration
2 Mar 2005
Neuren & Metabolic NRP Collaboration
28 Feb 2005
Appendix 4E Preliminary Final Report
7 Feb 2005
Former Pfizer Executive to join board
|
